To include your compound in the COVID-19 Resource Center, submit it here.

Olysio simeprevir regulatory update

Germany's Institute for Quality and Efficiency in Healthcare (IQWiG) said HCV drug Olysio simeprevir from Medivir and Johnson & Johnson's Janssen Research & Development LLC unit offers "major" additional

Read the full 295 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE